OR WAIT null SECS
Recipharm is investing EUR3.7 million (approximately $4.18 million) to increase lyophilization capacity at its Masate facility in Italy.
CDMO Recipharm has announced plans to expand its lyophilization capacity in Masate, Italy, to meet growing customer demand. An investment of EUR3.7 million (approximately $4.18 million) has been set aside for this expansion. A new lyophilizer will be purchased, bringing the total number of machines from five to six.
The CDMO offers lyophilization services for both vials and ampoules. The Masate facility specializes in aseptic manufacturing of parenterals.
Recipharm also invested EUR32 million (approximately $36 million) in Wasserburg, Germany in an ongoing project to increase lyophilization capacity at that site.